Sorry, you need to enable JavaScript to visit this website.
Today’s most successful adherence programs are no longer one-way communications solely about the product. Rather, they employ a more holistic approach that encourages patient interaction.
Every patient is unique and every patient’s journey is unique. That’s why it’s important to allow the patient to drive the topics and the cadence of the engagement based on what’s happening in that patient’s journey at that particular time....
Medical monitoring is an essential component of the clinical research process. Medical monitors provide medical expertise and oversight for the entire clinical trial, from initial study design through final study close-out. They ensure the clinical i...
Recently I had an interesting question posed to me. Someone asked me to help explain to management at his company what happens when the drug safety (DS)/pharmacovigilance (PV) group does not do a good job! Management wanted to know why they needed to...
In the course of many years in pharma heading drug safety groups and now consulting, training and doing outreach to the public, I continue to be amazed and humbled by the lack of knowledge by the public about drug safety and what those little pills y...
As the saying goes, children are not small adults. Children differ markedly from adults in terms of biology and physiology. In particular, how they handle drugs is quite different. Thus the approach of pharmacovigilance to SAEs and AEs in children ne...
While the pharmaceutical industry has been incorporating patient-centered practices within engagement and adherence programs for quite some time, the truth is that functional silos limit the ability for companies to fully adopt patient centricity at ...
There are a number of practical use cases for pharma companies to monitor social media: evaluating industry trends, conducting competitor analysis, monitoring product feedback, or tracking product safety concerns.